Latest news
25 items- PRAVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate SecretaryVALENCIA, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ:RCEL, ASX: AVH))), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced the appointment of Nicole Linda Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary, effective July 1, 2024. Ms. Kelsey has more than two decades of executive legal experience with expertise in M&A, securities, and governance, along with a strong track record building and leading global regulatory and compliance programs. Previously, she served as Chief Legal Officer and Secretary for Amyris, Inc. (NASDAQ:AMRS) and General Counse
- NEWSWill Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs InRoy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028. This growth would be primarily fueled by the expansion of adult-use markets and adoption of new licensed and regulated markets, both medical and recreational. Key states driving this surge include New York, New Jersey and potentially Florida and Ohio, Bingham says. Influence Of DEA Rescheduling Following the DEA's decision to reclassify cannabis to Schedule III, Bingham predicts this will open up new avenues for medical research and investment. "We expect major medical discoveries within five years," he stated, highlighting the potential for new pharm
- SECSEC Form S-8 POS filed by Amyris Inc.S-8 POS - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form S-8 POS filed by Amyris Inc.S-8 POS - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form S-8 POS filed by Amyris Inc.S-8 POS - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form S-8 POS filed by Amyris Inc.S-8 POS - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form POS AM filed by Amyris Inc.POS AM - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form POS AM filed by Amyris Inc.POS AM - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form S-8 POS filed by Amyris Inc.S-8 POS - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form S-8 POS filed by Amyris Inc.S-8 POS - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form S-8 POS filed by Amyris Inc.S-8 POS - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form S-8 POS filed by Amyris Inc.S-8 POS - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form POS AM filed by Amyris Inc.POS AM - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form S-8 POS filed by Amyris Inc.S-8 POS - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form POS AM filed by Amyris Inc.POS AM - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form S-8 POS filed by Amyris Inc.S-8 POS - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form S-8 POS filed by Amyris Inc.S-8 POS - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form POS AM filed by Amyris Inc.POS AM - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form S-8 POS filed by Amyris Inc.S-8 POS - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form POS AM filed by Amyris Inc.POS AM - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form POS AM filed by Amyris Inc.POS AM - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form POS AM filed by Amyris Inc.POS AM - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form POS AM filed by Amyris Inc.POS AM - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form POS AM filed by Amyris Inc.POS AM - AMYRIS, INC. (0001365916) (Filer)
- SECSEC Form S-8 POS filed by Amyris Inc.S-8 POS - AMYRIS, INC. (0001365916) (Filer)
AMRS FAQ
7 questionsWhat does Amyris Inc. do?
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty markets through its consumer brands and as a supplier of sustainable and natural ingredients in Europe, the United States, Asia, Brazil, and internationally. It manufactures and sells products for the health and wellness, clean beauty, and flavor and fragrance markets. The company operates under the Amyris, Biofene, Biossance, Pipette, Purecane, and No Compromise trademarks. Amyris, Inc. has a collaboration agreement with the Infectious Disease Research Institute to advance a novel ribonucleic acid...Where does AMRS stock trade?
Amyris Inc. (AMRS) is listed on NASDAQ.What sector and industry is AMRS in?
Amyris Inc. operates in the Industrials sector, Major Chemicals industry.When did Amyris Inc. go public?
Amyris Inc. (AMRS) completed its IPO in 2010.What are analysts saying about AMRS?
Amyris Inc. has had 8 recent analyst actions on file. The most recent action was from Jefferies: Hold with a $65.00 price target on 2023-05-18. Recent price targets range from $65.00 to $250.00.What companies are similar to AMRS?
Notable peers in the same industry include LIN (Linde plc), APD (Air Products and Chemicals Inc.), DOW (Dow Inc.), LYB (LyondellBasell Industries NV), ALB (Albemarle Corporation). Compare AMRS side-by-side with any of them on Quantisnow.How can I track AMRS on Quantisnow?
Quantisnow aggregates Amyris Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow AMRS to receive live email and push alerts on every new disclosure.